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Epilepsy is one of the most common neurological diseases. 
It manifests itself as a disorder of the central nervous system 
that is caused by repetition of abnormal, excessive and syn-
chronous neural discharge [1]. Such neural discharges are 
clinically manifested with epileptic seizures, and a dia-
gnosis of epilepsy is made if seizures are repeated two or 
more times. Possible causes of epilepsy are various: genetic 
disorders, birth trauma, anoxia, infection, traumatic head 
injury, stroke, and many others, but in approximately one 
third of patients the cause of epilepsy is unknown. Seizures 
have a major impact on the health of patients - each new 
seizure could cause micro damage to the brain and the pa-
tients could possibly be hurt during the attack. Also, seizu-
res affect the quality of life of patients - often people suffe-
ring from epilepsy have problems with employment and 
promotion opportunities. For many of them a driver’s licen-
se could be denied, and also there is significant effect on 
the social life because of the frequent isolation from friends 
and constant uncertainty whether the seizure will happen.
Consequently, the main goal of treatment in patients with 
epilepsy is partial or complete reduction of seizures. The 
treatment is usually pharmacological (anti-epileptic drugs 
– AED), with one, two or more AEDs. However, there are 
great difficulties with the pharmacoresistant form of epi-
lepsy, in which seizures continue after two years of tre-
atment and / or after unsuccessful treatment with a com-
bination of two to three antiepileptic drugs [2]. According 
to available literature, in about 50% of people with epi-
lepsy only one AED is sufficient for complete seizure 
reduction, but the problem is that about 36% of patients 
have pharmacoresistant form of epilepsy [3].
Patients with pharmacoresistant epilepsy are treated with in-
vasive methods, such as vagus nerve stimulation or one of 
neurosurgical procedures. The vagus nerve stimulation in 
combination with drug therapy can be very beneficial. For 
the purpose of stimulation, the vagus nerve stimulator is im-
planted in the left chest and the wire electrode is wrapped 
around the left vagus nerve [1]. The vagus nerve stimulator 
works on the assumption that stimulation of the nerve vagus 
sensory fibres can desynchronize cortical activity and reduce 
the incidence and severity of the epileptic seizures [1]. Ano-
ther possibility for the treatment of pharmacoresistant epi-
lepsy is surgical resection of epileptic regions of the brain. It 
is recommended to perform surgical resection as soon as it 
is determined that it is the only possible treatment , because 
the long term, frequent and severe attacks can lead to serious 
damage of the brain tissue and significantly affect cognitive 
and motor abilities of patients with epilepsy.
The result of the surgical resection is removing one part of 
the brain, and is of great importance that before the resecti-
on areas responsible for the generation of epileptic seizures 
are localized with great precision, but it is of equal impor-
tance to determine whether these areas can be removed 
without fatal consequences to neurological and cognitive 
function. For this purpose, detailed preoperative assessment 
designed to accurately predict the outcome of the surgery 
and to preserve the quality of life of patients is performed.
The preoperative assessment and invasive monitoring is be-
ing performed since 2010 at the Department of Neurology, 
University Hospital Center Zagreb, as part of the Referral 
Centre for Epilepsy of the Ministry of Health of the Republic 
of Croatia, led by Prof. Sanja Hajnšek. A multidisciplinary 
team consisting of neurologists, neurosurgeons, neuroradio-
logists and medical engineers participates in this extremely 
demanding procedure. The procedure is highly personalized. 
It requires a high  degree of expertise and knowledge, and 
careful selection of patients based on a detailed preoperative 
evaluation (determination of the semiology of the seizures, 
epi leptogenic lesion detection, and detection of the epi-
leptogenic zone [4]). After the selection of patients, the pre-
operative evaluation is performed, which precedes the neu-
rosurgical procedure of removing epileptic tissue.
Preoperative evaluation can be divided into two phases: Pha-
se I - non-invasive procedures and Phase II - invasive proce-
dures. Phase I includes: preoperative neuropsychological and 
neurocognitive testing, cognitive evoked potentials, EEG 
polygraph video recording, magnetic resonance (MR - 3T), 
MR volumetric analysis (particularly hippocampal sclerosis), 
functional MR recording with MR tractography, MR spe-
ctroscopy, and ‘postprocessing’ MR methods. Examples of 
the results of the MRI are shown in Figure 1.
Also, the functional imaging methods are performed, 
such as PET (positron emission tomography), SPECT 
(single-photon emission computed tomography) and 
SISCOM (Subtraction ictal SPECT co-registered to the 
MR) which presents comparison of ictal and interictal 
SPECT co-registered to MR ( Figure 2).
Fig. 1: a) MR-3T with marked area of the lesion and b) functional 
MRI with a location of Fasciculus arcuatus
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Based on the results obtained in the Phase I of the preopera-
tive evaluation, the more detailed location of the area of in-
terest is known, which is necessary for the Phase II. The 
Phase II consists of invasive procedures that will provide 
detailed information about the exact location of the epilepto-
genic tissue that has to be removed. Also, the Phase II emp-
hasizes the value of the invasive monitoring, because it 
shows what would happen if the epileptic tissue is removed 
and what impact it will have on the patient’s quality of life.
Invasive stage of the preoperative evaluation consists of 
the Wada test and invasive EEG monitoring. In the Wada 
test one hemisphere of the brain is temporarily anesthe-
tized with certain amount of anaesthetic in order to see 
what impact the absence of one hemisphere would have 
on motor and cognitive functions of patients [5]. Altho-
ugh the Wada test is the golden rule of lateralisation of 
speech function, it is important to assess for each patient 
the ratio between risks and complications related to this 
method and the postoperative benefit.
Invasive EEG monitoring is a procedure that determines the 
exact location of the epileptic zone for the neurosurgical 
resection, but also at the same time maps areas of the cortex 
responsible for speech, cognitive, motor and sensory fun-
ctions. Special electrodes for invasive monitoring are im-
planted into the patient, and EEG activity is monitored over 
several days (24 hour a day) with a 128-channel EEG am-
plifier. Based on the data obtained from methods in Phase 
I, for each patient it is determined which electrodes are 
required for invasive monitoring and precise location whe-
re electrodes should be implanted. There are several types 
of electrodes, they can vary in their form and way of im-
plantation (surface electrodes or deep electrodes). Figure 3 
shows a schematic view of the location of the electrodes (a) 
and a realistic view of the location (b). From the data obta-
ined from invasive monitoring about the location of the 
epileptogenic zone, neurosurgeons determine the trajectory 
of the neurosurgical resection.
Anatomy of the brain (gyrus and sulci) and the organizati-
on of brain functions are specific for each person. Therefo-
re it is necessary to determine whether the area of the epi-
leptogenic zone, which is planned for neurosurgical 
resection, also contains areas of the brain associated with 
motor control, sensors, and cognitive functions or speech. 
The “brain mapping”, whose main role is to preserve the 
quality of life of the patient after surgery, should be perfor-
med for every patient. “Brain mapping” is performed with 
the cortical stimulator and a battery of tests, where electri-
cal stimulation of individual electrodes simulates the disa-
bling brain tissue beneath these electrodes to determine 
what would happen if that piece of brain tissue is removed. 
The battery of tests is very carefully selected with the pur-
pose to examine cognitive, motor and sensory functions. 
During the procedure, the stimulation is performed with 
two by two electrodes and the intensity of the stimulation 
is gradually increased. During the test, it is important to 
record all the changes that the patient feels regarding the 
motor, sensory, and cognitive functions and speech.
Based on the results of the testing, for each patient the 
functional brain map is defined (shown in Figure 4). The 
functional brain map is very important for the planning 
of the neurosurgical resection because it provides insight 
into which motor, sensory or cognitive functions are re-
lated to the area of  the epileptogenic zone, and which 
part of the brain tissue could be removed without adver-
se consequences for the patient.
Based on the information obtained from the invasive 
monitoring, the neurosurgical removal of epileptic tissue 
is performed.
The success of the procedure is evaluated according to the 
quality of life of the patient after the surgery, measured 
with a degree of the reduction of epileptic seizures while 
preserving all motor, sensory and cognitive functions.
Fig. 2: SISCOM – subtraction of ictal from interictal SPECT and 
correlation with MRI; the connection between functional and 
morphological information, the area of the epileptogenic activity 
is marked
Fig. 3: Electrode scheme (a) and realistic representation (b)
Fig. 4: The functional brain map: individual presentation of sen-
sory and motor areas related to the epileptogenic zone; red line 
– primary sensor area, green line – primary motor area, yellow 
line – area of lesion, blue line – epileptogenic area
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